2-26465671-C-G
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_194248.3(OTOF):c.4799+1G>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_194248.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_194248.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTOF | NM_194248.3 | MANE Select | c.4799+1G>C | splice_donor intron | N/A | NP_919224.1 | |||
| OTOF | NM_194323.3 | MANE Plus Clinical | c.2498+1G>C | splice_donor intron | N/A | NP_919304.1 | |||
| OTOF | NM_001287489.2 | c.4799+1G>C | splice_donor intron | N/A | NP_001274418.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTOF | ENST00000272371.7 | TSL:1 MANE Select | c.4799+1G>C | splice_donor intron | N/A | ENSP00000272371.2 | |||
| OTOF | ENST00000339598.8 | TSL:1 MANE Plus Clinical | c.2498+1G>C | splice_donor intron | N/A | ENSP00000344521.3 | |||
| OTOF | ENST00000402415.8 | TSL:1 | c.2558+1G>C | splice_donor intron | N/A | ENSP00000383906.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152244Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251414 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461776Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727206 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74380 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change affects a donor splice site in intron 38 of the OTOF gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in OTOF are known to be pathogenic (PMID: 18381613, 19250381, 22575033). This variant is present in population databases (rs200147906, gnomAD 0.003%). Disruption of this splice site has been observed in individuals with auditory neuropathy spectrum disorder (PMID: 32476384, 34424407). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at